Patent intelligence · US
US 12383585
Methods of treatment of infections using bacteria
Methods of treatment of infections using bacteria
Patent details — US 12383585
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 12, 2025
- Expiration
- Aug 7, 2045
- Applicant
- Indaptus Therapeutics, Inc.
- Claims
- 8
- CPC classes
- A61K, A61K2039/521, A61K2039/55594, A61K35/74
Quick answer
US 12383585 (Methods of treatment of infections using bacteria) is held by Indaptus Therapeutics, Inc.. Status: granted. Granted Aug 12, 2025. Expires Aug 7, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Indaptus Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 8
- CPC classes
- A61K, A61K2039/521, A61K2039/55594, A61K35/74, A61K38/212, A61K39/0258
Frequently asked questions
What is US patent 12383585?
US 12383585 (Methods of treatment of infections using bacteria) is held by Indaptus Therapeutics, Inc.. Status: granted. Granted Aug 12, 2025. Expires Aug 7, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12383585?
Indaptus Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1 pharmaceutical patents for this assignee.
When does US 12383585 expire?
Our index shows an expiration date of Aug 7, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.